AlzChem Group AG
AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, f… Read more
AlzChem Group AG (ALZCF) - Net Assets
Latest net assets as of September 2025: $236.17 Million USD
Based on the latest financial reports, AlzChem Group AG (ALZCF) has net assets worth $236.17 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($590.56 Million) and total liabilities ($354.39 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $236.17 Million |
| % of Total Assets | 39.99% |
| Annual Growth Rate | 72.59% |
| 5-Year Change | 202.18% |
| 10-Year Change | N/A |
| Growth Volatility | 43.28 |
AlzChem Group AG - Net Assets Trend (2008–2024)
This chart illustrates how AlzChem Group AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for AlzChem Group AG (2008–2024)
The table below shows the annual net assets of AlzChem Group AG from 2008 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $207.47 Million | +26.85% |
| 2023-12-31 | $163.56 Million | +12.07% |
| 2022-12-31 | $145.95 Million | +62.95% |
| 2021-12-31 | $89.56 Million | +30.45% |
| 2020-12-31 | $68.66 Million | +11.91% |
| 2019-12-31 | $61.35 Million | -10.30% |
| 2018-12-31 | $68.39 Million | +18.13% |
| 2017-12-31 | $57.89 Million | -- |
| 2016-12-31 | $0.00 | -- |
| 2015-12-31 | $0.00 | -- |
| 2014-12-31 | $0.00 | -- |
| 2013-12-31 | $1.94K | -78.14% |
| 2012-12-31 | $8.86K | -29.71% |
| 2011-12-31 | $12.61K | -26.85% |
| 2010-12-31 | $17.24K | -38.84% |
| 2009-12-31 | $28.19K | -15.78% |
| 2008-12-31 | $33.48K | -- |
Equity Component Analysis
This analysis shows how different components contribute to AlzChem Group AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 22859447326.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $186.84 Million | 90.91% |
| Common Stock | $101.76 Million | 49.51% |
| Total Equity | $205.54 Million | 100.00% |
AlzChem Group AG Competitors by Market Cap
The table below lists competitors of AlzChem Group AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jastrzebska Spotka Weglowa SA
WAR:JSW
|
$417.73 Million |
|
Hexatronic Group AB (publ)
PINK:HTROF
|
$417.76 Million |
|
Zhongzhu Medical Holdings Co Ltd
SHG:600568
|
$417.81 Million |
|
Inter & Co Inc
SA:INBR32
|
$417.84 Million |
|
Marimekko Oyj
PINK:MKKOF
|
$417.61 Million |
|
Jenkem Technology Co Ltd
SHG:688356
|
$417.34 Million |
|
Zhejiang Jihua Group Co Ltd
SHG:603980
|
$417.31 Million |
|
Shinyoung Securities Co. Ltd.
KO:001720
|
$417.22 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in AlzChem Group AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 161,625,000 to 205,537,000, a change of 43,912,000 (27.2%).
- Net income of 54,075,000 contributed positively to equity growth.
- Dividend payments of 12,212,000 reduced retained earnings.
- Share repurchases of 1,512,000 reduced equity.
- Other comprehensive income increased equity by 21,639,000.
- Other factors decreased equity by 18,078,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $54.08 Million | +26.31% |
| Dividends Paid | $12.21 Million | -5.94% |
| Share Repurchases | $1.51 Million | -0.74% |
| Other Comprehensive Income | $21.64 Million | +10.53% |
| Other Changes | $-18.08 Million | -8.8% |
| Total Change | $- | 27.17% |
Book Value vs Market Value Analysis
This analysis compares AlzChem Group AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.47x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 736.75x to 5.47x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | $0.15 | $110.45 | x |
| 2009-12-31 | $0.13 | $110.45 | x |
| 2010-12-31 | $0.08 | $110.45 | x |
| 2011-12-31 | $0.06 | $110.45 | x |
| 2012-12-31 | $0.04 | $110.45 | x |
| 2013-12-31 | $0.01 | $110.45 | x |
| 2014-12-31 | $-185.74 | $110.45 | x |
| 2015-12-31 | $-185.83 | $110.45 | x |
| 2016-12-31 | $-0.23 | $110.45 | x |
| 2017-12-31 | $5.47 | $110.45 | x |
| 2018-12-31 | $6.58 | $110.45 | x |
| 2019-12-31 | $5.87 | $110.45 | x |
| 2020-12-31 | $6.57 | $110.45 | x |
| 2021-12-31 | $8.64 | $110.45 | x |
| 2022-12-31 | $14.21 | $110.45 | x |
| 2023-12-31 | $15.89 | $110.45 | x |
| 2024-12-31 | $20.20 | $110.45 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently AlzChem Group AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 26.31%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.76%
- • Asset Turnover: 1.15x
- • Equity Multiplier: 2.35x
- Recent ROE (26.31%) is above the historical average (-10.24%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -14.39% | 0.00% | 0.00x | 1.97x | $-8.16K |
| 2009 | -18.74% | 0.00% | 0.00x | 2.33x | $-8.10K |
| 2010 | -63.50% | 0.00% | 0.00x | 3.21x | $-12.67K |
| 2011 | -36.71% | 0.00% | 0.00x | 1.38x | $-5.89K |
| 2012 | -42.27% | 0.00% | 0.00x | 1.59x | $-4.63K |
| 2013 | -228.45% | 0.00% | 22091.00x | 7.05x | $-4.62K |
| 2014 | 0.00% | 0.00% | 11827.87x | 0.00x | $4.14 Million |
| 2015 | 0.00% | -0.01% | 8934.81x | 0.00x | $4.12 Million |
| 2016 | 0.00% | -0.01% | 5081.38x | 0.00x | $-23.65K |
| 2017 | 36.63% | 5.76% | 1.26x | 5.03x | $14.83 Million |
| 2018 | 33.81% | 6.03% | 1.20x | 4.68x | $15.95 Million |
| 2019 | 30.08% | 4.78% | 1.10x | 5.73x | $12.00 Million |
| 2020 | 29.44% | 5.19% | 1.07x | 5.30x | $13.00 Million |
| 2021 | 31.49% | 6.53% | 1.12x | 4.31x | $18.83 Million |
| 2022 | 20.87% | 5.54% | 1.28x | 2.94x | $15.65 Million |
| 2023 | 21.42% | 6.40% | 1.27x | 2.63x | $18.46 Million |
| 2024 | 26.31% | 9.76% | 1.15x | 2.35x | $33.52 Million |
Industry Comparison
This section compares AlzChem Group AG's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $7,181,833,981
- Average return on equity (ROE) among peers: 7.11%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| AlzChem Group AG (ALZCF) | $236.17 Million | -14.39% | 1.50x | $417.65 Million |
| AirBoss of America Corp (ABSSF) | $197.00 Million | -16.19% | 1.24x | $57.06 Million |
| Asia Carbon Industries Inc (ACRB) | $19.13 Million | 17.11% | 0.33x | $0.98 |
| Aimia Inc (AIMFF) | $1.29 Billion | -4.63% | 2.83x | $103.68 Million |
| L'Air Liquide S.A (AIQUF) | $11.83 Billion | 14.08% | 1.26x | $107.70 Billion |
| Akzo Nobel N.V (AKZOF) | $7.58 Billion | 14.03% | 1.29x | $9.73 Billion |
| Albemarle Corp (ALB) | $545.00 Million | 9.41% | 1.09x | $19.53 Billion |
| ALPEK S.A.B. de C.V (ALPKF) | $49.59 Billion | 15.64% | 1.50x | $214.40 Million |
| Altech Batteries Limited (ALTHF) | $97.54 Million | -5.87% | 0.01x | $27.89 Million |
| Arcadium Lithium plc (ALTM) | $333.00 Million | 14.14% | 0.12x | $6.26 Billion |
| Alto Ingredients Inc (ALTO) | $345.21 Million | 13.35% | 0.40x | $212.84 Million |